CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.
Generic Name: Lumiracoxib
Brand Name: Prexige
Manufacturer: Novartis Pharmaceuticals Canada Inc.
Indications: Osteoarthritis (Knee)
Submission Type: Initial
Project Status: Complete
Date Recommendation Issued: July 25, 2007
Recommendation Type: Do not list
